We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$165B
| $47.7M | 0.32% |
753,977
-105,100
| -12% | -$7.35M |
|
|
CELG
77
DELISTED
Celgene Corp
CELG
| $47.3M | 0.31% |
750,098
+56,679
| +8% | +$4.18M |
|
78
CVS Health
CVS
$122B
| $46.4M | 0.31% |
705,955
+52,296
| +8% | +$3.9M |
|
79
UGI
UGI
$7.33B
| $45.7M | 0.3% |
870,559
+70,877
| +9% | +$3.94M |
|
80
Lam Research
LRCX
$390B
| $45.5M | 0.3% |
3,399,340
+164,170
| +5% | +$2.35M |
|
81
Netflix
NFLX
$309B
| $45.3M | 0.3% |
1,760,690
-20,410
| -1% | -$611K |
|
82
IBM
IBM
$224B
| $44.3M | 0.29% |
404,417
-69,267
| -15% | -$8.31M |
|
83
Ecolab
ECL
$79.9B
| $41.3M | 0.27% |
284,203
-39,771
| -12% | -$6.07M |
|
84
Adobe
ADBE
$105B
| $41.2M | 0.27% |
181,609
-29,490
| -14% | -$7.12M |
|
85
Prudential Financial
PRU
$41.8B
| $40.3M | 0.27% |
494,190
-21,771
| -4% | -$2.01M |
|
86
PayPal
PYPL
$50.5B
| $39.4M | 0.26% |
464,329
-115,002
| -20% | -$9.58M |
|
87
Royal Bank of Canada
RY
$293B
| $39.2M | 0.26% |
575,684
+75,360
| +15% | +$5.5M |
|
88
NVIDIA
NVDA
$5.42T
| $38.7M | 0.26% |
11,694,720
+879,640
| +8% | +$4.21M |
|
89
Stryker
SYK
$130B
| $38.6M | 0.26% |
248,701
+22,274
| +10% | +$3.73M |
|
90
Morgan Stanley
MS
$340B
| $38.4M | 0.25% |
964,631
+219,543
| +29% | +$9.58M |
|
91
Nike
NKE
$61.9B
| $37.9M | 0.25% |
510,909
+77,961
| +18% | +$5.83M |
|
92
Caterpillar
CAT
$387B
| $37.7M | 0.25% |
295,722
-57,662
| -16% | -$7.5M |
|
93
Roper Technologies
ROP
$39.8B
| $37.5M | 0.25% |
140,992
+18,033
| +15% | +$5.1M |
|
94
Walmart Inc
WMT
$890B
| $37.4M | 0.25% |
1,210,404
-222,861
| -16% | -$7.15M |
|
95
Aflac
AFL
$62.6B
| $37.4M | 0.25% |
829,019
-11,338
| -1% | -$504K |
|
96
Marathon Petroleum
MPC
$83.7B
| $37.4M | 0.25% |
630,723
+307,344
| +95% | +$21M |
|
97
TC Energy
TRP
$65.9B
| $36.7M | 0.24% |
1,014,160
+23,944
| +2% | +$944K |
|
98
Prologis
PLD
$133B
| $35.6M | 0.24% |
612,155
+81,377
| +15% | +$5.27M |
|
99
TJX Companies
TJX
$178B
| $35.2M | 0.23% |
798,629
+115,515
| +17% | +$5.84M |
|
100
Xylem
XYL
$28.1B
| $35M | 0.23% |
534,428
+109,609
| +26% | +$7.58M |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.